Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Overview of attention for article published in Molecular Cancer Therapeutics, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 54,199 followers.

🐬 進行した子宮頸癌患者から血液を採取し、循環腫瘍細胞（CTC）を検出して、CTCが全生存期間や無再発生存期間に与えている影響について評価した。 https://t.co/4KQM9DX6fW

RT @NatRevClinOncol: Analysis of CTCs in pts with cervical cancer enrolled in the phase III Gynecologic Oncology Group 0240 trial reveals t…

Analysis of CTCs in pts with cervical cancer enrolled in the phase III Gynecologic Oncology Group 0240 trial reveals that only those with pre-treatment CTC counts above the median derived PFS and OS benefits from bevacizumab: https://t.co/lzzWHaYOUG #ca…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.